VNIM
AZN icon

Vaughan Nelson Investment Management’s AstraZeneca AZN Stock Holding History

Vaughan Nelson Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
12,975
+2,620
+25% +$493K 0.02% 157
2026
Q1 		$2.04M Sell
10,355
-726
-7% -$140K 0.02% 159
2025
Q4 		$2.04M Sell
11,081
-782
-7% -$137K 0.02% 157
2025
Q3 		$1.82M Buy
+11,863
New +$1.8M 0.02% 165

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Vaughan Nelson Investment Management's AZN Position: Q2 2026 in Review

Vaughan Nelson Investment Management increased its AstraZeneca (AZN) stake by 25% in Q2 2026, buying an estimated $493K and bringing the position to 12,975 shares worth $2.46M. The position accounts for 0.02% of the portfolio, ranked #157.

Vaughan Nelson Investment Management first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Vaughan Nelson Investment Management held 12,975 shares of AstraZeneca worth $2.46M as of Q2 2026.
  • Vaughan Nelson Investment Management bought 2,620 AstraZeneca shares in Q2 2026, an estimated $493K.
  • AstraZeneca made up 0.02% of Vaughan Nelson Investment Management's portfolio in Q2 2026, its #157 holding.
  • Vaughan Nelson Investment Management first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.